[ad_1]
“Today, the National Institute of Pharmacy and Nutrition (OGYEI) has approved the Sinopharm vaccine,” he said.
Last week, Hungary also became the first EU country to grant a conditional license for a Russian-produced COVID-19 Sputnik V vaccine.
The Hungarian government announced last Friday that it had agreed to buy a large quantity of Russian COVID-19 “Sputnik V” vaccines, although these vaccines have not yet been approved by the European Medicines Agency (EMA).
“Hungary has reached an agreement with Russia to purchase a large quantity of Sputnik V vaccine in three stages; negotiated contract and [praėjusią] Hungary’s Foreign Minister Peter Szijjarto said in a video statement.
The statement was posted on Mr. Siyart’s Facebook account on the Facebook network after a meeting with the Russian health minister in Moscow.
Mr. Szijjarto added that more details will be announced later on Friday.
The contract was signed the day after Hungary became the first country in the European Union to approve a vaccine developed by Sputnik V and AstraZeneca and the University of Oxford.
Hungary has repeatedly criticized what it calls the slow approval and procurement of vaccines in the European Union.
Under the bloc’s EEA rules, national regulators can issue temporary licenses for vaccines in emergency situations.
Amsterdam-based EVA is currently evaluating the vaccine at AstraZeneca and the University of Oxford, and has said a decision on its approval could be made by the end of next week.
However, the EVA does not consider Russian vaccines.
[ad_2]
